BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21094384)

  • 1. Uncertainty of measurement for summed masses: application to controlled substances.
    Wallace J
    Anal Chim Acta; 2010 Dec; 683(1):78-83. PubMed ID: 21094384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bottom-up approach in estimating the measurement uncertainty and other important considerations for quantitative analyses in drug testing for horses.
    Leung GN; Ho EN; Kwok WH; Leung DK; Tang FP; Wan TS; Wong AS; Wong CH; Wong JK; Yu NH
    J Chromatogr A; 2007 Sep; 1163(1-2):237-46. PubMed ID: 17628571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proficiency testing as a basis for estimating uncertainty of measurement: application to forensic alcohol and toxicology quantitations.
    Wallace J
    J Forensic Sci; 2010 May; 55(3):767-73. PubMed ID: 20345793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances.
    Barroso O; Miller J; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industrial employee drug screening: a blind study of laboratory performance using commercially prepared controls.
    Knight SJ; Freedman T; Puskas A; Martel PA; O'Donnell CM
    J Occup Med; 1990 Aug; 32(8):715-21. PubMed ID: 2401928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The meaning of the bias uncertainty measure.
    Bartley DL
    Ann Occup Hyg; 2008 Aug; 52(6):519-25. PubMed ID: 18535088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUBPART F--drug testing laboratories.
    Occup Health Saf; 2000 Apr; 69(4):40-6, 109. PubMed ID: 11396026
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimising uncertainty in physical sample preparation.
    Lyn JA; Ramsey MH; Damant AP; Wood R
    Analyst; 2005 Nov; 130(11):1507-12. PubMed ID: 16222372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction of the alkylnitrite method for the measurement of ethanol in blood: direct experimental evidence].
    Barinskaia TO; Salomatin EM; Smirnov AV
    Sud Med Ekspert; 2011; 54(2):42-5. PubMed ID: 21735717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an analytical method for the simultaneous determination of cocaine and its main metabolite, benzoylecgonine, in human hair by gas chromatography/mass spectrometry.
    Barroso M; Dias M; Vieira DN; Queiroz JA; López-Rivadulla M
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3320-6. PubMed ID: 18819113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental determination of calibration settings for plastic syringes containing solutions of 90Y using commercial radionuclide calibrators.
    Zimmerman BE; Cessna JT; Millican MA
    Appl Radiat Isot; 2004; 60(2-4):511-7. PubMed ID: 14987694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.
    Thevis M; Loo JA; Loo RR; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(3):297-304. PubMed ID: 17200979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposals and current practices in quality control.
    Kelly DT; Kelly ME
    Am J Med Technol; 1981 Dec; 47(12):957-64. PubMed ID: 7332017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of measurement uncertainty of glucose in clinical chemistry.
    Berçik Inal B; Koldas M; Inal H; Coskun C; Gümüs A; Döventas Y
    Ann N Y Acad Sci; 2007 Apr; 1100():223-6. PubMed ID: 17460183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finnish guidelines for workplace drug testing.
    Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Sep; 55(172):36317-8. PubMed ID: 10170592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sampling, storage and transport of biological materials collected from living and deceased subjects for determination of concentration levels of ethyl alcohol and similarly acting substances. A proposal of updating the blood and urine sampling protocol].
    Wiergowski M; Reguła K; Pieśniak D; Galer-Tatarowicz K; Szpiech B; Jankowski Z
    Arch Med Sadowej Kryminol; 2007; 57(2):223-30. PubMed ID: 17691181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method development for the quantitation of ABT-578 in rabbit artery tissue by 96-well liquid-liquid extraction and liquid chromatography/tandem mass spectrometric detection.
    Ji QC; Zhang J; Rodila R; Watson P; El-Shourbagy T
    Rapid Commun Mass Spectrom; 2004; 18(19):2293-8. PubMed ID: 15384150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.